- cafead   Jun 02, 2022 at 07:52: PM
via Transition Bio officially debuted Thursday morning with $50 million in Series A financing led by Northpond Ventures with participation from Taiho Ventures, Bristol Myers Squibb and Magnetic Ventures. The company plans to utilize its microfluidics-driven drug discovery platform and AI tools to map and modulate biomolecular condensates.
article source
article source